OHDSI Digest – May 9th, 2016

OHDSI MEETINGS THIS WEEK
Patient Visualization Work Group Meeting – Tuesday at 2pm ET
– Webex: https://jjconferencing.webex.com/mw0401lsp13/mywebex/default.do?service=1&main_url=%2Fmc0901lsp13%2Fe.do%3Fsiteurl%3Djjconferencing%26AT%3DMI%26EventID%3D386219722%26MTID%3Dmcad14cd8ab3f94c3de90668079be00a5%26Host%3DQUhTSwAAAAI1biuIj-1Atqgne4Ri-lVqG4mXenNij5b5Cvdm5LQpsAkL0pCgoUhMSFUC4_0jGxlpU8UgZN4R45in4DiJQORj0%26FrameSet%3D2&siteurl=jjconferencing&nomenu=true
– Teleconference: 1-877-5659999 (US)
– Access code: 881 735 36

NLP Work Group Meeting – Wednesday at 2pm ET
– Screen Sharing: https://global.gotomeeting.com/join/707196421
– Dial +1 (571) 317-3122 (United States)
– Enter conference ID: 707-196-421

ANNOUNCEMENTS
Congratulations to Christophe Lambert for his successful PCORI proposal:
http://www.pcori.org/research-results/2016/longitudinal-comparative-effectiveness-bipolar-disorder-therapies

Patrick Ryan’s OHDSI demonstration from the 2015 OHDSI symposium is now available online:
http://www.ohdsi.org/2015-ohdsi-symposium-materials/

OHDSI Symposium 2016 – Call for participation
The symposium organizing committee is now accepting submission abstracts for posters or software demonstrations at the second annual OHDSI Symposium to be held on September 23rd, 2016 at the Washington Hilton in Washington, DC.
Deadline to submit abstracts – June 15th 2016
http://www.ohdsi.org/ohdsi-symposium-2016-call-for-participation/

COMMUNITY PUBLICATIONS
Applying attribute based access control for privacy preserving health data disclosure
http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=7455820&tag=1

Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries
http://www.ncbi.nlm.nih.gov/pubmed/25907076

A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
http://www.ncbi.nlm.nih.gov/pubmed/26946292

Potential utility of precision medicine for older adults with polypharmacy: a case series study
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846041/